Antibiotic medicines: Use case
Use cases
Each use, its share of demand and volume, how critical the product is to it and why, and the price paid
| Use case | Volume | Unit | Criticality | Reason | Price | Price unit | Year | Source |
|---|---|---|---|---|---|---|---|---|
| Treating bacterial infections in people worldwide (use per 1,000 people per day, 2018) | 14.3 | defined daily doses per 1,000 people per day | Essential | Judgement: no practical substitute for treating serious bacterial infection; the GRAM study counts 1.14 million deaths attributable to bacterial antimicrobial resistance in 2021. | – | – | 2018 | [3][7] |
| Treating bacterial infections in low- and middle-income countries (2018 rate; up 76% from 2000) | 13.1 | defined daily doses per 1,000 people per day | Essential | Judgement: the rate rose 76% between 2000 and 2018 while high-income rates stayed stable. | – | – | 2018 | [3] |
| Treating bacterial infections in India's private sector | 5.07 billion | defined daily doses (10.4 per 1,000 people per day) | Essential | Judgement: antibiotics are sold on prescription in India and no substitute is named in the sources opened. | – | – | 2019 | [4] |
| Children's treatment bought through UNICEF (amoxicillin dispersible tablets; UNICEF's observed demand and procurement) | 320 million | tablets in 2017 | Important | Judgement: other antibiotics could be used, at a cost and with different resistance patterns. | 0.22 | US$ per course for a child under one year | 2017 | [10] |
as of 2026-11-14
Industries that buy it
The industries and kinds of firm that buy it, for which use case, and how critical it is to them
Used by- Healthcare services Treatment of bacterial infections · criticality essential Clinics and hospitals prescribe antibiotics; in India they may be sold by retail only on a registered medical practitioner's prescription [17]. No share by setting was found.
- Retail and online pharmacies Retail sale in India · criticality essential A press report on the Koya et al. study says the private sector accounts for 85 to 90% of India's antibiotic consumption [5]; the share sold by pharmacies was not found.
as of 2026-11-14
What it competes with
The products and technologies that compete with it in each use case
Competes with- Vaccines Preventing bacterial infections so that fewer antibiotics are needed Only a partial swap, for the infections that have a vaccine. WHO estimates that vaccines against 23 pathogens, including some still to be developed, could cut the antibiotics needed by 22%, or 2.5 billion defined daily doses a year [21]; no cost comparison was found.
as of 2026-11-14
How it is used
Lifetime, use per year and utilisation, by variant
| Measure | Value | Unit | Place | Year | Source |
|---|---|---|---|---|---|
| Antibiotic use, world average | 14.3 | defined daily doses per 1,000 people per day | World | 2018 | [3] |
| Antibiotic use, low- and middle-income countries | 13.1 | defined daily doses per 1,000 people per day | World | 2018 | [3] |
| Antibiotic use, private sector | 10.4 | defined daily doses per 1,000 people per day | India | 2019 | [4] |
| Share of that use in formulations not approved by the central regulator (as the study gives it; 2,408 of 5,071 million doses is 47.5% by calculation) | 47.1 | % of defined daily doses | India | 2019 | [4] |
| Share of that use in the single most used formulation, azithromycin 500 mg tablet (press report on the study) | 7.6 | % | India | 2019 | [5] |
| Highest national antibiotic use rate among countries in the 2000 to 2018 study (the lowest was 5.0) | 45.9 | defined daily doses per 1,000 people per day (highest country) | World | 2018 | [3] |
as of 2026-11-14
Prices
Unit prices by market or use, with year and source
| Market | Value | Unit | Year | Source |
|---|---|---|---|---|
| UNICEF indicative price per treatment course of amoxicillin dispersible tablets, child under one year | 0.22 | US$ per course | 2018 | [10] |
| UNICEF indicative price per treatment course of amoxicillin dispersible tablets, child over one year | 0.44 | US$ per course | 2018 | [10] |
| India, NPPA ceiling price of azithromycin 500 mg tablet (price control) | 11.67 | Rs per tablet | 2024 | [19] |
| United States, price of penicillin as production grew, July 1943 | 20 | US$ per dose | 1943 | [12] |
| United States, price of penicillin three years after July 1943 (year calculated) | 0.55 | US$ per dose | 1946 | [12] |
as of 2026-11-14
Sources
- Global antibiotic consumption rates increased by 46 percent since 2000 University of Oxford (news on Browne et al., Lancet Planetary Health), 2021, news item of 16 November 2021
- Consumption of systemic antibiotics in India in 2019 (Koya, Ganesh, Selvaraj, Wirtz, Galea, Rockers) The Lancet Regional Health - Southeast Asia, vol. 4, p. 100025 (record on DOAJ), 2022, abstract only
- Over 47 per cent antibiotic formulations used in India in 2019 unapproved: Lancet study ThePrint (PTI report on the Koya et al. study), 2022, 7 September 2022; secondhand press report
- Antibiotic resistance has claimed at least one million lives each year since 1990 University of Oxford (news on the GRAM study in The Lancet), 2024, news item of 17 September 2024 (date from the web address); GRAM study 'Global burden of bacterial antimicrobial resistance 1990 to 2021'
- Amoxicillin Dispersible Tablets: Market and Supply Update UNICEF Supply Division, 2018, May 2018; Tables 1, 3 and 4
- Penicillin: Opening the Era of Antibiotics US Department of Agriculture, Agricultural Research Service, 2024, page last modified 8 February 2024
- Rational Use Of Antibiotics For Limiting Antimicrobial Resistance: CDSCO lists down steps for Pharma cos, chemists and drug controllers Medical Dialogues, 2019, 26 December 2019, Medical Dialogues Bureau; secondhand report of a CDSCO notice
- NPPA Hikes Prices of Key Antibiotics Azithromycin, Amoxicillin Clavulanic Acid Medical Dialogues, 2025, 12 February 2025, by Farhat Nasim; reports the review order dated 4 October 2024
- Better use of vaccines could reduce antibiotic use by 2.5 billion doses annually, says WHO World Health Organization, 2024, 10 October 2024; corrected on 24 October 2024 to 23 pathogens